James R Sulat Net Worth & Insider Trades
James R Sulat - Director, Arch Therapeutics, Inc
What is James R Sulat's Net Worth?
The current estimated net worth of Arch Therapeutics, Inc's Director, James R Sulat, is estimated to be about $10.41M . James R Sulat owns about 1,746,813 units of Arch Therapeutics, Inc common stock. In the last 5 years at Arch Therapeutics, Inc, James R Sulat has sold an estimated value of $0 worth.
What is James R Sulat's Past Insider Trading?
James R Sulat's largest purchase order was 454,546 units , worth over $81.82K on June 23, 2020. In total, James R Sulat has made about 8 transactions over 5 years of their time at Arch Therapeutics, Inc. James R Sulat usually trades in May and July, with the busiest year in 2016 and 2018.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
James Sulat
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What are Arch Therapeutics, Inc's Past Insider Trades?
Arch Therapeutics, Inc's most recent insider trade came on September 8, 2023 by Michael Abrams who bought 10,292 units worth $2.83K . In the last 7 years, insiders at Arch Therapeutics, Inc have bought an estimated value of $0 worth of shares. Insider trading is most common in July, with the busiest year in 2022. The most active traders at the company are Terrence Norchi, PRESIDENT AND CHIEF EXECUTIVE, James Sulat, Director, and Avtar S Dhillon, Director .
Arch Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||